Agenus | AGEN - Capital De Empréstimo

Preço das Ações
3.82
Mudança Diária
0.07 1.87%
Mensal
-14.16%
Anual
31.27%
Q2 Previsão
3.74




Capital De Empréstimo Alterar Data
AbbVie USD 58.94B 4.03B 2025-12
Agenus USD 169.66M 146.06M 2025-12
Amgen USD 51.89B 1.88B 2026-03
AstraZeneca USD 25.96B 177M 2026-03
Bristol-Myers Squibb USD 42.15B 698M 2026-03
CSL USD 10.42B 273M 2025-12
Eli Lilly USD 39.37B 1.5B 2026-03
Gilead Sciences USD 20.86B 1.27B 2026-03
GlaxoSmithKline GBP 14.01B 696M 2026-03
Glaxosmithkline GBP 19.82B 203.13M 2025-12
Incyte USD 29.41M 785K 2026-03
Intrexon USD 0 198.67M 2024-06
J&J USD 37.53B 1.91B 2026-03
Jiangsu Hengrui CNY 37.1M 6.2M 2026-03
Karyopharm Therapeutics USD 278.22M 278.22M 2025-12
MacroGenics USD 70M 256K 2025-12
Merck EUR 10.73B 277M 2025-12
Merck USD 46.67B 77M 2026-03
Northwest Biotherapeutics USD 31.8M 11.49M 2025-09
Novartis USD 37.45B 7.86B 2026-03
Novavax USD 246.3M 200K 2025-12
Pfizer USD 60.57B 1.08B 2026-03
Regeneron Pharmaceuticals USD 1.99B 719.7M 2026-03
Rigel Pharmaceuticals USD 0 0 2024-09
Sangamo BioSciences USD 0 0 2022-06
Veracyte USD 0 0 2025-03